Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study.
about
Consensus treatment plans for new-onset systemic juvenile idiopathic arthritisOpen label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolongSerum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy.Hematopoietic stem cell transplantation for auto immune rheumatic diseasesReview: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?The management of osteoporosis in children.2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening aUrine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis.Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions.A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis.2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.Systemic arthritis in children: a review of clinical presentation and treatmentTargeting the inflammasome in rheumatic diseases.Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade.Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome.Influence of past breast feeding on pattern and severity of presentation of juvenile idiopathic arthritis.Changes of Platelet Indices in Juvenile Idiopathic Arthritis in Acute Phase and After Two Months Treatment.Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study.Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis.Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations.Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management.Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.Treatment of refractory autoimmune diseases with autologous stem cell transplantation: focus on juvenile idiopathic arthritis.Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition.Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.Atopy in children with systemic onset juvenile idiopathic arthritis (SoJIA) is associated with a worse outcome.Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study.The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives.
P2860
Q24610145-7C4CC674-4CD2-4C66-AA63-6134E71C9A51Q24812856-87504234-B9FC-41DF-9AF1-20E88D288726Q24817009-8CEE02B4-68B6-42BD-A499-F4226CAE7B29Q26751425-FE8FCE96-2879-450D-A975-18C168A8937AQ27002805-066364D4-ABC4-4C27-B0E9-6E623A5540CCQ30251490-E781CB0D-8CDA-46FD-B803-21280F9E604DQ33613293-39AE65A1-190E-42B0-803B-4119D8F2B4FAQ34268714-18DA92C2-ECFB-4600-86CF-654A02838743Q34269827-4E097BC1-61E9-4E94-BEB2-F32CE99F8714Q34758768-2046B933-642B-4615-ACD1-26ABAA4A15DBQ35041117-CD724D51-3B29-48B8-B840-4944A9753A80Q35567870-4AC318E1-B429-4ABD-97DD-4321734E51EAQ35659928-66B0474C-144D-4BDD-8AC2-0E3932FEE929Q35804717-25F07278-768F-4E2A-9069-F7793ECF921EQ36229664-205B18EE-7F17-452F-AF75-F92E17839007Q36403583-7D9CC661-8A3F-4AFB-951D-77638601F9DDQ36577397-3A0C0EB4-4352-4209-B0B9-B6F1AC15AF53Q36762031-AC30E261-1F75-413F-9963-07D932EF6612Q37182199-1183F3EE-B38C-4F6E-95C5-7D576A8EDF57Q37451624-E81BB4C7-96FC-431A-8CFA-AE23A91C2EAFQ37462544-9BC18F71-1CA2-4F9E-8529-4879AAFCCAB5Q37747792-CA143946-63E3-4F42-9BA2-8A46B0DEC7ECQ37803416-488DB354-8CA3-465C-8C5C-8B0DF139C480Q38406386-F837600D-53DE-43CB-AD1F-427B3873E39AQ38750832-781EE676-E154-4FE2-A002-EFF0CA4AF668Q40335671-B32AEF8A-2694-4BD9-9F21-0702F24D5E5EQ40432675-567C9428-DEFA-4790-9CBA-2197F438A466Q47150341-EB6BA911-C850-4A81-8DF9-3C9D81D09630Q48514200-3DCAFBE5-3483-463E-B98D-68C2A963E75EQ51155090-BD160F39-FC47-4323-9719-F9B7DF2A2C30Q51740150-C49FCCBB-0E2F-44B9-B5C0-699FC99F50F2Q55206915-0B411CD9-3D2C-4A61-A91C-43712BF0A9CE
P2860
Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Early predictors of poor funct ...... s: a multicenter cohort study.
@en
type
label
Early predictors of poor funct ...... s: a multicenter cohort study.
@en
prefLabel
Early predictors of poor funct ...... s: a multicenter cohort study.
@en
P2093
P1476
Early predictors of poor funct ...... s: a multicenter cohort study.
@en
P2093
Feldman BM
Schneider R
Silverman ED
Spiegel LR
Stephens D
P2860
P304
P356
10.1002/1529-0131(200011)43:11<2402::AID-ANR5>3.0.CO;2-C
P577
2000-11-01T00:00:00Z